Target intelligence / Profile preview

Family with sequence similarity 218 member A (FAM218A)

Target
FAM218A
Molecular classification
Other (lncRNA, uncharacterized protein)
01

Overview

Family with sequence similarity 218 member A (FAM218A) encodes an RNA designated as a long non-coding RNA (lncRNA), and may also give rise to a protein (Protein FAM218A) whose functional properties are not well characterized[5][3]. It is also known by alternative names such as C4orf39, TRIM61-AS1, and others[5][3]. FAM218A is mapped to human chromosome 4q32.3[7]. There is no evidence to date that FAM218A acts as a therapeutic target such as a receptor, enzyme, ion channel, or transporter[5][1][3]. The biological function of FAM218A remains unclear: no conclusive molecular role or involvement in signal transduction, cell cycle regulation, or known signaling pathways has been reported[5][3]. Disease associations are limited but include rare links to cone-rod dystrophy 13 and spondyloepiphyseal dysplasia Kimberley type, based on genetic studies, without clear mechanistic data[5]. There is no published evidence of approved drugs or mechanisms of action targeting FAM218A, nor is it established as a biomarker or known to present specific safety concerns[5][3][7].

Other names
Protein FAM218AC4orf39FLJ31659TRIM61-AS1TRIM61 antisense RNA 1uncharacterized protein C4orf39
02

Biological functions

Other (unknown/poorly characterized)
03

Disease associations

Other (cone-rod dystrophy 13, spondyloepiphyseal dysplasia Kimberley type)

Beyond the preview

Go deeper on Family with sequence similarity 218 member A (FAM218A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 218 member A (FAM218A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call